WallStSmart

HCA Healthcare, Inc. (HCA)vsThe Joint Corp (JYNT)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

HCA Healthcare, Inc. generates 134771% more annual revenue ($76.39B vs $56.64M). HCA leads profitability with a 8.9% profit margin vs 5.7%. HCA appears more attractively valued with a PEG of 1.12. HCA earns a higher WallStSmart Score of 63/100 (C+).

HCA

Buy

63

out of 100

Grade: C+

Growth: 5.3Profit: 8.0Value: 5.3Quality: 6.0
Piotroski: 5/9Altman Z: 1.71

JYNT

Hold

47

out of 100

Grade: D+

Growth: 6.0Profit: 5.5Value: 3.0Quality: 6.5
Piotroski: 6/9Altman Z: 0.86
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

HCASignificantly Overvalued (-85.7%)

Margin of Safety

-85.7%

Fair Value

$286.26

Current Price

$372.13

$85.87 premium

UndervaluedFair: $286.26Overvalued

Intrinsic value data unavailable for JYNT.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

HCA4 strengths · Avg: 9.3/10
Return on EquityProfitability
136.3%10/10

Every $100 of equity generates 136 in profit

Debt/EquityHealth
-7.9110/10

Conservative balance sheet, low leverage

Market CapQuality
$80.58B9/10

Large-cap with strong market position

P/E RatioValuation
12.5x8/10

Attractively priced relative to earnings

JYNT3 strengths · Avg: 8.7/10
Return on EquityProfitability
20.9%9/10

Every $100 of equity generates 21 in profit

Debt/EquityHealth
0.139/10

Conservative balance sheet, low leverage

EPS GrowthGrowth
43.8%8/10

Earnings expanding 43.8% YoY

Areas to Watch

HCA2 concerns · Avg: 4.0/10
Revenue GrowthGrowth
4.3%4/10

4.3% revenue growth

Altman Z-ScoreHealth
1.714/10

Distress zone — elevated risk

JYNT4 concerns · Avg: 2.5/10
Market CapQuality
$118.18M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
5.7%3/10

5.7% margin — thin

PEG RatioValuation
8.832/10

Expensive relative to growth rate

P/E RatioValuation
92.1x2/10

Premium valuation, high expectations priced in

Comparative Analysis Report

WallStSmart Research

Bull Case : HCA

The strongest argument for HCA centers on Return on Equity, Debt/Equity, Market Cap. PEG of 1.12 suggests the stock is reasonably priced for its growth.

Bull Case : JYNT

The strongest argument for JYNT centers on Return on Equity, Debt/Equity, EPS Growth. Revenue growth of 13.3% demonstrates continued momentum.

Bear Case : HCA

The primary concerns for HCA are Revenue Growth, Altman Z-Score.

Bear Case : JYNT

The primary concerns for JYNT are Market Cap, Profit Margin, PEG Ratio. A P/E of 92.1x leaves little room for execution misses.

Key Dynamics to Monitor

HCA carries more volatility with a beta of 1.19 — expect wider price swings.

JYNT is growing revenue faster at 13.3% — sustainability is the question.

HCA generates stronger free cash flow (895M), providing more financial flexibility.

Monitor MEDICAL CARE FACILITIES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

HCA scores higher overall (63/100 vs 47/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

HCA Healthcare, Inc.

HEALTHCARE · MEDICAL CARE FACILITIES · USA

HCA Healthcare is an American for-profit operator of health care facilities that was founded in 1968. It is based in Nashville, Tennessee, and, as of May 2020, owns and operates 186 hospitals and approximately 2,000 sites of care, including surgery centers, freestanding emergency rooms, urgent care centers and physician clinics in 21 states and the United Kingdom.

Visit Website →

The Joint Corp

HEALTHCARE · MEDICAL CARE FACILITIES · USA

The Joint Corp. The company is headquartered in Scottsdale, Arizona.

Visit Website →

Want to dig deeper into these stocks?